Argenx
ARGX
#472
Rank
HK$407.13 B
Marketcap
HK$6,474
Share price
0.78%
Change (1 day)
4.39%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): HK$123.35

According to Argenx 's latest financial reports the company's current EPS (TTM) is HK$124.06. In 2025 the company made an earnings per share (EPS) of HK$165.42 an increase over its 2024 EPS that were of HK$109.23.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$123.35-25.43%
2025HK$165.4251.44%
2024HK$109.23-369.77%
2023-HK$40.49-60.46%
2022-HK$102.4163.33%
2021-HK$62.70-40.37%
2020-HK$105.15183.47%
2019-HK$37.09123.09%
2018-HK$16.6354.93%
2017-HK$10.7314.07%
2016-HK$9.4113.05%
2015-HK$8.32-36.34%
2014-HK$13.07209.04%
2013-HK$4.23-33.99%
2012-HK$6.41185.59%
2011-HK$2.24